Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis

Skin Pharmacology and Applied Skin Physiology

Volumn 11, Issue 2, 1998, Pages 70-79

  Van Pelt, J P A ^a   De Jong, E M G J ^a   De Bakker, E S M ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD11b; CD18; ICAM 1; Inflammation; Integrins; Liarozole; Psoriasis

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CYTOCHROME P450; INTERCELLULAR ADHESION MOLECULE 1; INVOLUCRIN; LIAROZOLE; LIAROZOLE FUMARATE;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; DRY SKIN; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SIDE EFFECT; SKIN BIOPSY; SKIN INFLAMMATION;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CELL DIFFERENTIATION; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; DERMATITIS; ENZYME INHIBITORS; EPIDERMIS; FEMALE; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; NETHERLANDS; PROSPECTIVE STUDIES; PSORIASIS;

EID: 0031751374     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029811     Document Type: Article

References (30)

1. Fritsch PO: Retinoids in psoriasis and disorders of keratinization. J Am Acad Dermatol 1992;27:S8-S14.
2. Dowling JE, Wald G: Nutrition classics. Proceeding of the National Academy of Sciences of the United States of America, volume 46, 1960: The biological function of vitamin A acid: John E. Dowling and George Wald. Nutr Rev 1981;39:134-138.
3. Dowling JE, Wald G: Nutrition classics. Proceeding of the National Academy of Sciences of the United States of America, volume 46, 1960: The biological function of vitamin A acid: John E. Dowling and George Wald. Nutr Rev 1981;39:134-138.
4. Chytil F: Retinoic acid: Biochemistry, pharmacology, toxicology, and therapeutic use. Pharmacol Rev 1984;36:93S-100S.
5. Wolf G: Multiple functions of vitamin A. Physiol Rev 1984;64:873-937.
6. Pilkington T, Brogden RN: Acitretin. A review of its pharmacology and therapeutic use. Drugs 1992;43: 597-627.
7. Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 1994;84:446-452.
8. Li J, Sartorelli AC: Synergistic induction of the differentiation of WEHI-3B D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leuk Res 1992;16:571-576.
9. 4 induced intraepidermal accumulation of polymorphonuclear leukocytes. Br J Dermatol 1987;117: 297-300.
10. 4-induced migration of polymorphonuclear leukocytes into human skin. Arch Dermatol Res 1991;283:158-161.
11. van de Kerkhof PC, Chang A, van Dooren Greebe R, Geiger JM, Happle R: Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin. Acta Derm Venereol 1988; 68:499-503.
12. Blanchet Bardon C, Nazzaro V, Rognin C, Geiger JM, Puissant A: Acitretin in the treatment of severe disorders of keratinization. Results of an open study. J Am Acad Dermatol 1991;24:982-986.
13. Di Giovanni JJ, Helfgott RK, Gerben LH: Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med 1986;315:1177-1182.
14. Baden HP, Buxman MM, Weinstein GD, Yoder FW: Treatment of ichthyosis with isotretinoin. J Am Acad Dermatol 1982;6:716-720.
15. Ellis CN, Voorhees JJ: Etretinate therapy. J Am Acad Dermatol 1987; 16:267-291.
16. van Wauwe JP, Coene MC, Cools W, Goossens J, Lauwers W, Le Jeune L, van Hove C, van Nyen G: Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid. Biochem Pharmacol 1994;47: 737-741.
17. Elder JT, Kaplan A, Cromie MA, Kang S, Voorhees JJ: Retinoid induction of CRABP II mRNA in human dermal fibroblasts: use as a retinoid bioassay. J Invest Dermatol 1996;106:517-521.
18. Miller VA, Rigas JR, Muindi JR, Tong WP, Venkatraman E, Kris MG, Warrell RP Jr: Modulation of all-trans-retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol 1994;34:522-526.
19. 450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. J Pharmacol Exp Ther 1990;252:365-369.
20. 450-dependent enzymes as targets for prostate cancer therapy. J Steroid Biochem Mol Biol 1996;56: 133-143.
21. 450 enzyme inhibitors is compound- and cell-type specific. J Steroid Biochem Mol Biol 1996; 57:197-202.
22. Bruynseels J, de Coster R, van Rooy P, Wouters W: R 75251, a new inhibitor of steroid biosynthesis. Prostate 1990;16:345-357.
23. de Coster T, Coene MC, van Wauwe JP: Assessment of the multiple-dose pharmacokinetics of liarozole fumarate and its effect on the endocrine system in healthy male subjects. Clinical Research Report. Janssen-Cilag Foundation, N 106593/1, 1994.
24. Doncker P, Deree J, Degreef H: Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: An open study with oral liarozole. Br J Dermatol 1995; 133:426-432.
25. Kemeny L, Michel G, Dobozy A, Ruzicka T: Cytokine system as potential target for antipsoriatic therapy. Exp Dermatol 1994;3:1-8.
26. 450 inhibitors of use in medical treatment: Focus on mechanisms of action. Pharmacol Ther 1995;67:79-100.
27. 450: Progress and predictions. FASEB J 1992;6: 669-673.
28. van Wauwe JP, van Nyen G, Coene MC, Stoppie P, Cools W, Goossens J, Borghgraef P, Janssen PA: Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J Pharmacol Exp Ther 1992;261:773-779.
29. Smets G, van Ginckel R, Daneels G, Moeremans M: Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. Prostate 1995;27:129-140.
30. 450 inhibitor liarozole. Br J Dermatol 1997;136:71-75.